lobbying_activities: 2433402

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2433402	718772aa-eecf-4d8c-88bf-cd2fa3f455aa	Q1	WILLIAMS AND JENSEN, PLLC	41454	MERCK & CO INC	2020	first_quarter	BUD	Policies impacting Medicare Part D. Drug Development and Public Health Preparedness. Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201 Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748 CARES Act, Public Law No: 116-136.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office	80000		0	0	2020-04-17T16:20:51.220000-04:00